Episodios

  • PEOPLE VS POISON

    PEOPLE VS POISON
    Mar 3 2026
    “Food Babe” Vani Hari joins Del to expose what she calls a make-or-break moment for the food movement. With 180,000 cancer lawsuits, billions already paid out, and a lobbying machine entrenched in D.C., she warns Bayer is pushing toward Supreme Court immunity to avoid future liability. After a decade battling Monsanto, Vani says the window to act is closing—and is organizing a massive rally at the U.S. Supreme Court on April 27, 2025, “People vs. Poison,” to mobilize the public before it’s too late.

    Become a supporter of this podcast: https://www.spreaker.com/podcast/the-highwire-with-del-bigtree--3620606/support.
    Más Menos
    27 m
  • BACKLASH BUILDS OVER GLYPHOSATE MOVE

    BACKLASH BUILDS OVER GLYPHOSATE MOVE
    Mar 2 2026
    A new executive order aimed at ensuring an “adequate supply” of glyphosate-based herbicides is drawing backlash from MAHA leaders—who say it echoes the 1986 liability shield created under the National Childhood Vaccine Injury Act. They argue the move functions as a protection plan for manufacturers while limiting public recourse, and warn it could be a lobbyist-driven push to expand legal immunity for chemical companies. With public pressure now building, MAHA voices are urging viewers to mobilize—before glyphosate follows the same path vaccines did.

    Become a supporter of this podcast: https://www.spreaker.com/podcast/the-highwire-with-del-bigtree--3620606/support.
    Más Menos
    17 m
  • EPSTEIN FILES REVEAL POWER BROKERS IN SCIENTIFIC PUBLISHING

    EPSTEIN FILES REVEAL POWER BROKERS IN SCIENTIFIC PUBLISHING
    Feb 28 2026
    Newly surfaced documents and reporting are fueling questions about whether a small network of powerful players including Bill Gates, Jeffrey Epstein, and individuals linked to Robert Maxwell’s scientific publishing legacy sought outsized influence over how research is distributed and amplified. Emails, investments, and media-funding ties are being cited as potential indicators of an effort to shape which scientific ideas rise to prominence and which get sidelined. The broader issue: who controls the pipelines of modern science—publishing, PR, and perception—and what transparency is owed to the public when power concentrates behind the scenes.

    Become a supporter of this podcast: https://www.spreaker.com/podcast/the-highwire-with-del-bigtree--3620606/support.
    Más Menos
    9 m
  • Episode 465: ESSENTIAL ELEMENTS

    Episode 465: ESSENTIAL ELEMENTS
    Feb 27 2026
    This week on The HighWire, Del Bigtree tackles the MAHA moment head-on, starting with rising backlash over the Trump Administration’s recent action on glyphosate and concerns about expedited production tied to Roundup.

    Del is joined by Vani Hari (Food Babe) to discuss what’s happening right now in food policy and reform—and what it means for families.

    Plus, Jefferey Jaxen takes us deeper into the Epstein files, focusing on what’s coming to light around medical/science publishing and influence.

    And in a must-see in-studio interview, Del sits down with Dr. Michael Nehls on lithium—asking whether we’ve been missing (or denying) a truly essential element.

    Guests: Vani Hari, Dr. Michael Nehls


    Become a supporter of this podcast: https://www.spreaker.com/podcast/the-highwire-with-del-bigtree--3620606/support.
    Más Menos
    1 h y 54 m
  • Episode 464: STEEP TERRAIN

    Episode 464: STEEP TERRAIN
    Feb 21 2026
    Del Bigtree returns to the desk after two weeks in Europe with An Inconvenient Study, bringing shocking reports from doctors and scientists around the world — and a firsthand account of breaking four ribs in a Canadian ER that exposed the reality of mainstream emergency medicine.
    Jefferey Jaxen reports on a Super Bowl ad that backfired in spectacular fashion, raising serious questions about AI surveillance and corporate overreach.

    Then, an unfiltered roundtable with Alec Zeck, Dr. Ben Tapper, and Katie Collins, PA-C, tackling holistic health, informed consent, censorship, and the terrain theory vs. germ theory debate many have demanded, and few are willing to host.

    Guests: Katie Collins, PA-C, Dr. Ben Tapper, Alec Zeck


    Become a supporter of this podcast: https://www.spreaker.com/podcast/the-highwire-with-del-bigtree--3620606/support.
    Más Menos
    3 h y 30 m
  • $2M VERDICT A TURNING POINT IN GENDER MEDICINE

    $2M VERDICT A TURNING POINT IN GENDER MEDICINE
    Feb 17 2026
    A landmark jury verdict holding clinicians liable for malpractice tied to a teen gender-transition surgery is being viewed as a pivotal moment in the national debate over pediatric gender medicine. The ruling intensifies legal scrutiny, signals expanding statutes of limitations, and raises new questions from state and federal authorities about evidence standards, oversight, and the adequacy of informed consent in youth gender-related medical interventions.

    Become a supporter of this podcast: https://www.spreaker.com/podcast/the-highwire-with-del-bigtree--3620606/support.
    Más Menos
    15 m
  • WAS ‘AN INCONVENIENT TRUTH’ A VERY CONVENIENT LIE?

    WAS ‘AN INCONVENIENT TRUTH’ A VERY CONVENIENT LIE?
    Feb 16 2026
    Jefferey looks back at the 20-year legacy of “An Inconvenient Truth” highlighting long-standing factual disputes, court rulings on bias, and how climate narratives have been used to justify sweeping policies. Hear new research on polar bears, natural climate cycles, and the emerging risks of AI-engineered viruses—raising questions about which threats are real and which are manufactured through narrative.

    Become a supporter of this podcast: https://www.spreaker.com/podcast/the-highwire-with-del-bigtree--3620606/support.
    Más Menos
    10 m
  • TEXAS AG TAKES ON VACCINE INCENTIVES

    TEXAS AG TAKES ON VACCINE INCENTIVES
    Feb 14 2026
    Texas Attorney General Ken Paxton joins Del to discuss his new investigation into financial incentives that may influence pediatric vaccination practices. He outlines concerns about reimbursement structures, insurance policies, and COVID-era mandates that critics say altered medical decision-making and weakened informed consent. Paxton also weighs in on federal liability protections for vaccine manufacturers, hospital requirements, and the ongoing legal battles over parental rights in healthcare decisions.

    Become a supporter of this podcast: https://www.spreaker.com/podcast/the-highwire-with-del-bigtree--3620606/support.
    Más Menos
    24 m